Birthmarks are common and can take a toll on a child’s self-esteem and family dynamics. Birthmarks often go beyond the skin to involve the vascular or nervous systems, may be linked to cancer, and may be just one part of a larger syndrome with whole-body health effects.
PeDRA’s Birthmarks Focused Study Group is made up of physicians and scientists committed to understanding the biology underlying birthmarks and revealing new treatments. Priorities include exploring the use of beta-blockers in high-risk patients, exploring the phenotype-genotype correlation of overgrowth syndromes, and the search for novel genes of medical significance in birthmarks.
The Birthmarks Working Group is chaired by Joyce Teng, MD of Stanford University, and Jenna Streicher, MD of Indiana University.
- Assessment of current practices in management of infantile hemangioma
- Assessment of the Clinical Use and Outcomes of Sirolimus Treatment for Complex Vascular Anomalies
- Biomarkers of Neurovascular Complications in PHACE Syndrome
- Capillary Malformation-Arteriovenous Malformation Syndrome Guidelines
- Examining How Virtual Reality Improves Children’s Coping During Dermatologic Procedures
Studies Seeking Collaborators
Arnold, Justin, et al. “Characteristics and Complications of Anogenital Infantile Hemangiomas: A Multicenter Retrospective Analysis” Journal of the American Academy of Dermatology (2023).
Davies, Olivia, et al. “Early-onset hypertension associated with extensive cutaneous capillary malformations harboring postzygotic variants in GNAQ and GNA11” Pediatric Dermatology (2022).
Fernández Faith, Esteban, et al. “Incidence and clinical factors associated with ulceration in infantile hemangiomas” Journal of the American Academy of Dermatology (2022).
Davies, Olivia, et al. “Cutaneous vascular anomalies associated with a mosaic variant of AKT3: Genetic analysis continues to refine the diagnosis, nomenclature, and classification of vascular anomalies” Journal of the American Academy of Dermatology (2022).
Kittler, Nicole, et al. “Successful use of telemedicine for evaluation of infantile hemangiomas during the early COVID-19 pandemic: A cross-sectional study” Pediatric Dermatology (2022).
Partan, Elizabeth, et al. “Analysis of Whole Genome Sequencing in a Cohort of Individuals with PHACE Syndrome Suggests Dysregulation of RAS/PI3K Signaling” medRxiv (2021).
Davies, Olivia, et al. “Cutaneous mosaic RASopathies associated with rhabdomyosarcoma” Pediatr Blood Cancer (2022).
Cotton, Colleen, et al. “Association of Demographic Factors and Infantile Hemangioma Characteristics With Risk of PHACE Syndrome” JAMA Dermatology (2021).
Fernández Faith, Esteban, et al. “Clinical Features, Prognostic Factors, and Treatment Interventions for Ulceration in Patients With Infantile Hemangioma” JAMA Dermatology (2021).
Klein, Alyssa, et al. “Anesthetic techniques used for pulsed dye laser (PDL) in the treatment of port-wine birthmarks: An exploratory assessment of current attitudes and practice patterns among pediatric dermatologists in the United States” Pediatric Dermatology (2021).
Dodds, Melissa, et al. “Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series.” Pediatric Dermatology (2020).
Stefanko, Nicole, et al. “Hamartomas and midline anomalies in association with infantile hemangiomas, PHACE, and LUMBAR syndromes” Pediatric Dermatology (2020).
Stefanko, Nicole, et al. “Natural history of PHACE syndrome: A survey of adults with PHACE.” Pediatric Dermatology (2019).
Siegel, Dawn H., et al. “Analyzing the genetic spectrum of vascular anomalies with overgrowth via cancer genomics.” Journal of Investigative Dermatology (2018).
Active Member Locations
Send us an email to get connected to the Birthmarks group or to learn more.